Among adults with low platelet counts or bleeding symptoms from primary immune thrombocytopenia (ITP), treatment with Nplate® (romiplostim) produces a rapid increase in platelet counts. These results were presented at the 53rd Annual Meeting of the American Society of Hematology. Thrombocytopenia occurs when platelet levels fall below normal. It can often occur as a direct [...]
In a study of women with bone metastases from breast cancer, Xgeva™ (denosumab) delayed bone complications for five months longer than Zometa® (zoledronic acid). These updated results from a Phase III clinical trial were presented at the 2010 San Antonio Breast Cancer Symposium. Metastatic cancer refers to cancer that has spread to distant sites in [...]
Nplate® (romiplostim) appears to maintain platelet counts among adult patients with chronic immune (idiopathic) thrombocytopenia purpura (ITP) for more than five years. These results were presented at the 52nd Annual Meeting and Exposition of the American Society of Hematology. Thrombocytopenia occurs when platelet levels fall below normal. It can often occur as a direct result [...]
Xgeva™ (denosumab) has been approved by the US Food and Drug Administration (FDA) for the prevention of bone complications such as fracture in patients with bone metastases from solid (not blood-related) cancers. It is not approved for patients with multiple myeloma or other cancers of the blood. Metastatic cancer refers to cancer that has spread [...]
Among women with bone metastases from breast cancer, denosumab may be more effective than Zometa® (zoledronic acid) at delaying or preventing bone complications such as fracture. The results of this Phase III clinical trial were published in the Journal of Clinical Oncology. Metastatic cancer refers to cancer that has spread to distant sites in the [...]
Compared with standard therapies, Nplate® (romiplostim) appears to reduce the risk of treatment failure and need for splenectomy among adult patients with chronic immune thrombocytopenia (ITP). These results were published in the New England Journal of Medicine. Thrombocytopenia occurs when platelet levels fall below normal. It can often occur as a direct result of cancer, [...]
People with a history of cancer appear to be 40% more likely to experience memory problems than people with no history of cancer. These findings were recently presented at the Third American Association for Cancer Research Conference on The Science of Cancer Health Disparities. Previous, smaller studies have linked diagnoses of specific cancers (such as [...]
Most cancer patients who experience pain or depression also report many accompanying physical symptoms such as fatigue, difficulty sleeping, difficulty remembering things, and extremity, joint, or back pain. These patients also reported high healthcare use and significant disability days. These findings were recently published in the journal Archives of Internal Medicine.[1] Pain and depression are [...]
Early-stage breast cancer patients undergoing radiation therapy following breast-conserving surgery experienced significantly less skin irritation when they used a melatonin-containing cream compared with a placebo (a cream without melatonin). The results of this study were recently presented at the 2010 Breast Cancer Symposium.[1] Treatment for early-stage breast cancer often involves breast-conserving surgery (lumpectomy), which may [...]
Among patients with multiple myeloma or bone metastases from breast cancer, prostate cancer, or other solid tumors, denosumab was more effective than Zometa® (zoledronic acid) at delaying or preventing bone complications such as fracture. Results from an integrated analysis of Phase III clinical trials were presented at the 35th European Society for Medical Oncology (ESMO) [...]
